REGN
Regeneron Pharmaceuticals, Inc.
Ten-year history of valuation, safety, growth and profitability, with percentile bands against REGN’s own range.
Snapshot
P/E
12.4×
P14Yield
0.6%
P99FCF payout
10.7%
P28Net debt / EBITDA
-0.28
P57DGR 5y
n/a
ROIC
3.3%
P13Value
Is the share cheap or dear by its own history?
REGN is historically cheap. P/E at P14 (12.4x); yield at P99 (0.6%).
Safety
Can the business comfortably cover the dividend?
FCF payout sits at P28 (11%) of its history. Leverage (Net Debt/EBITDA) at P57 (-0.28); interest cover at P13 (129.14).
Growth
Is the dividend and the cash behind it still growing?
5-year dividend growth at n/a of its 10y range. FCF growth P11 (-8%); ROIC P13 (3%).
Partial data in this window.
Profitability
Is the engine getting better or worse at making money?
Gross margin at P23 (85%) of its history. Operating margin P4 (26%); net margin P24 (28%).
Forecast your income with the REGN dividend calculator
Free account
Sign up free to look up 10 stocks a day.
Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.